First Time Loading...
S

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505

Watchlist Manager
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Watchlist
Price: 7.73 CNY 0.39% Market Closed
Updated: May 5, 2024

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Revenue
¥850.7m
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Revenue?
Revenue
850.7m CNY

Based on the financial report for Dec 31, 2023, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Revenue amounts to 850.7m CNY.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
3%

Over the last year, the Revenue growth was -17%. The average annual Revenue growth rates for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd have been 1% over the past three years , 3% over the past five years .